Alvotech Presentations & Investor Relations material

Alvotech is a global biosimilar company dedicated to be one of the leaders in the monoclonal antibody market. Alvotech's headquarters are in Reykjavik, Iceland. The company is privately-owned, focused on developing and manufacturing biosimilar pharmaceutical products. Alvotech has already broken ground and laid the foundation for a 12,000 sqm new state of the art, fully vertically integrated biologics manufacturing plant, located on the campus of the University of Iceland in Reykjavik. Current biosimilar assets include follow-on versions of leading monoclonal antibodies molecules.